Melanie Matheu

Founder at Prellis Biologics, Inc.

Consumer Services

Health Technology

Finance

Profile

Melanie Matheu is the founder of Prellis Biologics, Inc., where she holds the title of Chief Technology Officer & Director.
She founded the company in 2016.
Dr. Matheu is currently working as an Advisor at Cantos Ventures, LLC.
In terms of education, she received a doctorate degree from the University of California, Irvine in 2009 and an undergraduate degree from UC Santa Barbara College of Engineering in 2001.

Melanie Matheu active positions

Companies	Position	Start
Prellis Biologics, Inc. Prellis Biologics, Inc. BiotechnologyHealth Technology Prellis Biologics, Inc. engages in building human tissues for drug development, and also develops human organs for transplantation. It offers vascularized tissue, bio and human organ printing. The firm's products include Organoid, Vascular Bundle, 3D Tissue Chip, Cell Seeding Matrix, Cell Adhesion Plus and Holograph-X Bioprinter. The company was founded by Noelle Huskey Mullin and Melanie Matheu in October 2016 and is headquartered in San Francisco, CA.	Founder	2016-09-30
Cantos Ventures, LLC Cantos Ventures, LLC Investment ManagersFinance Cantos Ventures LLC (Cantos Ventures) is a venture capital firm founded in 2016 by Ian Rountree. The firm is headquartered in San Francisco, California.	Consultant / Advisor	-

All active positions of Melanie Matheu

Training of Melanie Matheu

UC Santa Barbara College of Engineering	Undergraduate Degree
University of California, Irvine	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Melanie Matheu's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Prellis Biologics, Inc. Prellis Biologics, Inc. BiotechnologyHealth Technology Prellis Biologics, Inc. engages in building human tissues for drug development, and also develops human organs for transplantation. It offers vascularized tissue, bio and human organ printing. The firm's products include Organoid, Vascular Bundle, 3D Tissue Chip, Cell Seeding Matrix, Cell Adhesion Plus and Holograph-X Bioprinter. The company was founded by Noelle Huskey Mullin and Melanie Matheu in October 2016 and is headquartered in San Francisco, CA.	Health Technology
Cantos Ventures, LLC Cantos Ventures, LLC Investment ManagersFinance Cantos Ventures LLC (Cantos Ventures) is a venture capital firm founded in 2016 by Ian Rountree. The firm is headquartered in San Francisco, California.	Finance